人鼻咽癌放射抗拒性肿瘤干细胞的分离、筛选与鉴定

目的分离、筛选、鉴定人鼻咽癌CNE-2及放射耐受CNE-2R的肿瘤干细胞。方法免疫磁珠技术分选CNE-2及CNE-2R中鼻咽癌CD133+干细胞,分别用无血清培养法、平板克隆法、裸鼠成瘤试验检测分选的CD133+细胞体外增殖能力、克隆形成能力及成瘤能力,HE染色和电镜超微结构观察形态学变化。结果 CNE-2及CNE-2R细胞中CD133+表达分别为(1.79±0.16)%和(2.63±0.72)%;CNE-2-CD133+细胞及CNE-2R-CD133+细胞形成肿瘤干细胞球及体外增殖能力远高于CD133-表达者;CNE-2R-CD133+细胞克隆形成能力较CNE-2-CD133+细胞明显升高,而且CNE-2R-CD133+细胞的克隆形态与CNE-2-CD133+细胞相比较明显增大;形态学发现CNE-2R-CD133+细胞核大,异型,核仁大,细胞器肥大。结论分离、筛选出的鼻咽CNE-2R-CD133+肿瘤干细胞能形成干细胞球,其增殖能力、裸鼠成瘤能力更强,能为进一步探讨鼻咽癌放射抗拒的机制提供研究基础。     

肝动脉支永久性铸型栓塞治疗原发性肝癌

1985年3月起用氰基丙烯酸酯,经腹行肝动脉支铸型栓塞治疗原发性肝癌28例(Ⅰ甲期10例、Ⅱ乙期12例、Ⅲ期6例)。AFP降至正常6例,8例肿瘤难以显示。1例生存已逾32个月、健在。1年存活率52.9%(9/17),2年存活率20%(2/10)。为进一步延长生存期或达治愈目的:1.栓塞后早期肝切除,2.门静脉支内瘤栓的诊断和消灭,需采用综合治疗措施。肝癌合并肝硬化门脉高压症,可联合脾动脉结扎、胃冠状静脉栓塞术,治疗3例平均生存期已愈16个月。     

126例涎腺肿瘤的免疫组织化学研究

利用S-100蛋白抗体对126例涎腺肿瘤（多形性腺瘤、恶性多形性腺瘤、粘液表皮样癌、腺样囊性癌、基底细胞腺瘤和乳头状囊腺瘤等）进行了免疫组化研究。结果发现:5种肿瘤中都有瘤细胞或部分瘤细胞表达S-100蛋白;但乳头状囊腺瘤的肿瘤性上皮则呈S-100蛋白阴性反应。提示:S-100蛋白抗原在涎腺肿瘤性肌上皮细胞中均有表达。     

TSH RECEPTOR GENETIC ALTERATIONS IN THE AUTONOMOUSLYFUNCTIONING THYROID ADENOMAS

Objective To determine the relationship between TSH receptor gene mutations and autonomously functioning thyroid adenomas (AY‘]rAs). Methods The thyroid samples from 14 cases of diagnosed AFTAs were analyzed, with normal thyroid specimens adjacent to the tumors as controls. The 155 base pairs DNA fragments which encompassed the third cytoplasmic loop and the sixth transmembrane segments in the TSH receptor gene exon 10 were amplified by Polymerase chain reaction (PCR) and analyzed by the single-strand conformation polymorphism (SSCP). Direct sequencing of the PCR products was performed with Prism Dye Terminator Cycle Sequencing Core Kit.Results 6 of 14 AFTA specimens displayed abnormal migration in SSCP analysis. In sequence analysis of 3 abnormally migrated samples, one base substitution at nucleotide 1957 (A to C) and two same insertion mutations of one adenosine nucleotide between nucleotide 1972 and 1973 were identified. No mutations were found in controls. Conclusion This study confirmed the presence of TSH receptor gene mutations in AFTAs; both one-point substitution mutation and onebase insertion mutation were found to be responsible for the pathogenesis of AFTAs.     

肝动脉,门静脉双介入化疗治疗肝癌的研究

对４７例原发性肝癌患者采用皮下泵行双介入治疗，即对肝动脉栓塞化疗和门静脉灌注化疗，肝动脉门静脉双灌注化疗，临床结果表明：无论在临床症状改善，肿瘤缩小程度，治疗的有效还是延长生存期方面，栓塞组均比化疗组显著，而肝癌切除后局部预防组对肝癌复发的预防比周围预防组疗效显著，该方法操作简便，易于掌握，并发症少，提供了一条治疗肝癌的有效途径。     

SURVEY SUBAXIAL CERVICAL VERTEBRAE FOR TRANSPEDICULAR SCREW FIXATION

Therearemanycausesofsubaxialcervicalinstabilitysuch astrauma,degenerativedisease,neoplasm,andinfection.Therearenumerousinternalfixationproceduresthathavebeen usedforone stageposteriordecompressionandstabilizationof thecervicalspine.Recentlydevelopedposteriorplatescrew fixationprocedureshavebeenperformedinthecervicalspine byusingalateralmassscreworapediclescrewformal stage posteriordecompressionandstabilizationofthecervical spine[1].Theseveralpotentialrisksofneurovascularcomplica tions,whichare…     

人参皂甙20(R)-Rg_3治疗肺癌的临床疗效观察

~~人参皂甙20(R)-Rg_3治疗肺癌的临床疗效观察@陈明伟$西安交通大学第一医院呼吸内科!陕西西安710061 @陈健$西安交通大学第一医院呼吸内科!陕西西安710061 @姚煜$西安交通大学第一医院呼吸内科!陕西西安710061 @石志红$西安交通大学第一医院呼吸内科!陕西西安710061新药研究;;人参皂甙;;肺肿瘤~~     

犬急性肝衰模型的建立

目的　建立犬急性肝衰模型 ,以进一步探讨应用体外异种全肝灌注治疗急性肝衰的方法与效果。方法　选 7只犬予以戊巴比妥钠 2 5mg·kg-1腹腔注射麻醉 ,分别行一期门腔端侧分流 ,肝周韧带断离 ,膈动脉缝扎。肝动脉血流完全阻断 2h ,制备致死性肝衰模型。术中定时采血测ALT、AST、LDH、PT、FIB、ammonia。取犬肝组织行光镜、电镜观察。结果　 1只犬因麻醉过量致死 ,其余 6只均手术成功。所有犬均在全肝血流完全阻断后 (3～7.5h)死亡 ,平均生存时间 (5 .7± 1.2 )h。随全肝血流阻断时间延长 ,动物血ALT、AST、ammonia、LDH进行性升高 ,PT时间延长 ,PIB减少 ,血压进行性下降。结论　一期门腔分流、全肝血流完全阻断 2h制备犬急性肝衰模型方法简便、可靠。